Edwards Lifesciences (EW) Total Liabilities (2009 - 2026)

Edwards Lifesciences' Total Liabilities history runs 18 years deep, the most recent figure standing at $3.0 billion for Q1 2026.

• In Q1 2026, Total Liabilities rose 5.76% year-over-year to $3.0 billion; the TTM figure through Mar 2026 stood at $3.0 billion (up 5.76% YoY), while the FY2025 annual figure was $3.4 billion, up 12.27% from the prior year.
• Total Liabilities was $3.0 billion for Q1 2026 at Edwards Lifesciences, down from $3.4 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $3.4 billion in Q3 2024 to a low of $2.4 billion in Q3 2022.
• Historically, Total Liabilities has averaged $2.8 billion across 5 years, with a median of $2.6 billion in 2023.
• The sharpest annual moves came in 2024 and 2025: Total Liabilities gained 27.09% in 2024, then dropped 8.71% in 2025.
• A 5-year view of Total Liabilities shows it stood at $2.5 billion in 2022, then rose by 6.36% to $2.6 billion in 2023, then rose by 13.19% to $3.0 billion in 2024, then gained by 12.27% to $3.4 billion in 2025, then fell by 10.89% to $3.0 billion in 2026.
• The last three Total Liabilities figures came in at $3.0 billion (Q1 2026), $3.4 billion (Q4 2025), and $3.1 billion (Q3 2025), per Business Quant data.